The New Strategy To Reverse Aging

34
New strategy to reverse signs of aging SWSCC Educational Seminar & Suppliers Day August 23, 2012 - Las Colinas

description

The New Strategy To Reverse Aging by Dr Estella Loing

Transcript of The New Strategy To Reverse Aging

  • Newstrategytoreverse

    signsofaging

    SWSCC Educational Seminar & Suppliers Day

    August 23, 2012 - Las Colinas

  • Who is Unipex? 2

    questforeternallifeimmortality

    alchemistshuntedinvainfortherejuvenatingPhilosophersstone

  • SkinAging

    Chronologicalaging

    Photoaging

    External/Internalfactors:pollution,foods,alcohol,tobacco,emotions

    Genetic

  • Antiagingcream

    Plasticsurgery

    Makeupandphotoshop

    Strategiestoreverseskinaging SkinAging

  • Physiologicalchangeswithage

    Hyper orhypopigmentationSeborrheic keratoses

    Dry,scalyskinIncreaseinskinfragility(barrierfunction)

    Increaseinroughness,wrinklesLaxity

    EasybruisingDecreaseimmunefunction

    AGING

    MatureskinYoungskin

  • Stratumcorneum CompactFlaky

    Dermis

    Epidermis

    Hypodermis

    SC

    DEJ

    EpidermisThickness =properskinbarrier

    Keratinocytes,Mc: proliferation,maturationProteoglycanssynthesis

    Thick Thin

    ++++++

    DermislevelECMcomponent(collagens,elastin..)

    MMPsactivitiesImmunefunctions

    Low+++

    +++

    FlatDermal Epidermal junctionDermis/epidermiscohesion

    Wavy+++

    HypodermislevelSubcutaneousfat+++

    Skinchangeswithage

    AGING

  • Ourstrategytoreverseskinaging

    DermislevelECMcomponent(collagens,elastin..)

    MMPsactivitiesImmunefunctions

    Low

    Stratumcorneum CompactFlakyEpidermis

    Thickness =properskinbarrierKeratinocytes,Mc,proliferation,maturation

    Proteoglycanssynthesis

    Thick Thin

    ++++++

    FlatDermal Epidermal junctionDermis/epidermiscohesion

    Wavy

    Dermis

    Epidermis

    Hypodermis

    SC

    DEJ

    HypodermislevelSubcutaneousfat

    +++

    +++

    +++

    +++ +++ Progerin+/- Progerin

    AGING

  • Structuralagingduetosenescencemarker:progerin

    Lamin A/CFrom Cao et al. 2011

    Thisprocessofaginggallopstoaboutseventimesthenormalrate

    Progerin asanewmarkerofaging Progerin isanalteredformoftheLamin Aprotein(nuclearintermediatefilamentprotein) Accumulationofprogerin innucleus OriginallyassociatedwiththeHutchinsonGilfordSyndrome(=Progeria)

    Progerin andaccelerationofaging Accumulation ofprogerin inducesvariousdefectsinnuclearstructureandfunctions Alterationscellcycleprogressioncausedbyprogerin knowntoacceleratehumanaging

    1

  • Progerin is expressed in healthy cells (fibroblasts and terminally differentiated keratinocytes mainly) andaccumulated with age (3% per year)

    The same molecular mechanisms responsible for premature aging in progeria act at low level in healthy cells

    Cell nuclei from old individuals acquire defects similar to those of progeria patient cells

    Progerin inhealthycells

    Progerin hasbeenlinkedtophysiologicalageingaspresenceofprogerin isconcomitantwithalterationsofthedermalcompartment suchasdisorganizedconnectivetissue

    From Scaffidi et al. 2008

    1

    9yearsold 96yearsold Progeria

  • TT2 abiomimeticstructuralpeptideFocus on biomimetic peptide derived from structural proteins and enzymes implicated in the maintenance ofdermal structure and connective tissue organizationTT2 (INCI: F3Acetyl Tripeptide2) : 3 amino acid peptide derived biomimetic of Elafin, an enzyme inhibitor

    1

    Protocol Maturehumandermisfibroblastswereincubatedfor96hourswithTT2peptide TheprogerinwasquantifiedusinganELISAmethodology.Resultsaregiveninpgofprogerinpergofproteins

    TT2peptide decreasessignificantlytheproductionofprogerin,attestingitsefficacyonthesenescenceprocess

    22%inhibitionprogerin

    production

    TT2peptide

  • EffectofTT2peptide ondermalstructureandconnectivetissueorganization

    MMPs

    Elastase,collagenase

    Dermis contraction

    Syndecan

    Progerin

    MMP1,MMP3&MMP9inhibition

    1

    Progelinecontrol Progelinecontrol

    T0 After24h

    +27%collagen contraction

    TT2peptide TT2peptide

  • EffectofTT2peptide ondermalstructureandconnectivetissueorganization

    MMPs

    Elastase,collagenase

    Dermis contraction

    Syndecan

    Progerin

    1

    Control +collagenase +collagenase +Progeline

    Collagenfibers

    43%inhibitioncollagenase

    TT2peptide

    100%inhibitionelastase

    Elastinfibers

    Control +Elastase +Elastase +ProgelineTT2peptide

  • 13

    EffectofTT2ondermalstructureandconnectivetissueorganization

    MMPs

    Elastase,collagenase

    Dermis contraction

    Syndecan

    Progerin

    Bymodulangsenescenceprocess(progerin),

    TT2peptide inducesseveralbiological

    responsesatthedermis&epidermislevels

    1

  • ClinicalStudiesFirmness,Laxity

    1

  • Clinicalevaluationofantisaggingeffectonjawlines

    TT2peptide decreasessignificantlythevolumeofthejawlinesafter28and56days

    Protocol

    10healthyvolunteers :5464yearsoldwithagedskin Formulation:2%TT2peptide emulsion creamorplacebo Application:splitface andsplitneck 2X/dayfor56days Measurementofthevolumeofthejawlines ofthefacebyinvivo

    fringeprojectionprofilometry

    80%ofvolunteers had animprovement

    1

    TT2peptide2%

  • Clinicalevaluationoffirmness&elasticityCutometryProtocol

    13healthyvolunteers(54 66yearsold)withsaggyskin(lossoffirmness,slackeningskin) Formulation:2%TT2peptideemulsioncreamorplacebo Application:splitface andsplitneck 2X/dayfor28days Measurementsareperformedonbothcheeks(diameterprobe=2mm)bycutometry

    1

    Improvement upto: 93%ofcutaneous elasticity 82%ofcutaneous firmness 42%ofcutaneous viscoelasticity

    TT2peptide increasessignificantlyfirmness,elasticityandviscoelasticityafter28days

    TT2peptide2%

  • D0

    Slight improvement

    Majorbuildingeffect overtime!

    Clinicalevaluationoffirmness&elasticity 1

    TT2peptide

  • Summary TT2peptideeffect 1

    SyndecanDermis contractionElastase,collagenasesProgerine

    LaxityFirmness,Elasticity

    Reverseeffect ofTT2peptide

  • Ourstrategytoreverseskinaging

    DermislevelECMcomponent(collagens,elastin..)

    MMPsactivitiesImmunefunctions

    Low

    Stratumcorneum CompactFlakyEpidermis

    Thickness =properskinbarrierKeratinocytes,Mc,proliferation,maturation

    Proteoglycanssynthesis

    Thick Thin

    ++++++

    FlatDermal Epidermal junctionDermis/epidermiscohesion

    Wavy

    Dermis

    Epidermis

    Hypodermis

    SC

    DEJ

    HypodermislevelSubcutaneousfat

    +++

    +++

    +++

    +++

    1 2

  • Youngskin

    Fullfatcompartments

    Matureskin

    Deflatedfatcompartments

    Nasolabialwrinkles

    Structural agingduetolipoatrophy 2

  • Hormesis concept 2

    Concept launched by Givenchy with Vaxin (2010) :This vaccinelike serum is formulated with a unique complex capable ofgenerating microstimuli, which encourage the skin's cells to produce theirown agedefying protein HSP70

    The word hormesis comes from the greek root hormeticos, which meansstimulation and the first mention of the term hormesis in the open scientificliterature was published in 1943

    - ++

    ++

    Hormesis : homeostatic and adaptative beneficial response of cells to microstressexposure in order to correct a physiological imbalance

  • Activationofadipocyteanabolism

    Adipogenesisactivation

    (adipocytedifferenciation)

    LipolysisInhibition

    (freefattyacidrelease)

    Lipogenesisactivation

    (triglyceridesynthesis)

    Adiposetissuegrowth

    HIF1

    +

    Lipohormesis Newproprietarypatentedconcept 2

    Lipohormesis = hormesis applied to adipose tissue

    Various stresses in the adipose tissue are able to stimulate its expansion through theactivation of Hypoxia Inducible Factor (HIF1), a transcription factor

    ReverseagingWrinklereduction

    Plumperskin

    Youngskin

    Matureskin

  • L.O. Alipofillinglikealternative 2 LO(INCI:Ornithine(and)Phospholipids(and)Glycolipids):Lornithine,anaminoacid

    obtainedbybiotechnologyfromvegetablestarch,encapsulatedinaIonosome

    Ionosome: new generation of delivery system (proprietary patented). Polysaccharidecoated encapsulation: polysaccharides (stearoyl inulin) inserted in the

    phospholipid membrane = protective coating

    Ionosome benefits: Resistantdeliverysystem Highpenetrationcapacitytotargetadipocytes Higherefficacy

    Lipophilicside

    Hydrophilicside

    C18

    C18

    C18

    C18

    L-ornithine

    LO

  • LOreproduceslipohormesis phenomenonandmimics lipofilling result byincreasingfatty tissuevolumewith aglobalaction

    2EffectofLOontheactivationofHIF1andadipocyteanabolismProtocol Human preadipocytes were isolated from biopsiesandcultivated fordifferentiation. 0.02%LO was added onadipocytesculture Genic expressionwas evaluated through cDNA methodology

    ResultsAdipofill

    HIF1

    genes involvedinadipogenesis

    genes involved inlipolysis

    genes involvedinlipogenesis

    Adipocytedifferenciation

    Freefatty acidrelease

    Triglyceridesynthesis

  • LOinhibitslipolysisanddecreasesthereleaseoffattyacidsfromadipocytesbyincreasinglipidstorage

    Protocol

    Lipidstorageenhancement lipolysis 2

    Increase insize

    Increase inlipid content

    Humanadipocyteobtainedfromapieceofsurgicalresectionwereincubatedwith0.05%and0.2%LO Free fatty acids (NEFA) were quantified in the media using a spectrophotometric method and the adipocyte

    size was evaluated through the measurement of their average diameter after staining with red oil (specific forlipids)

    LO

    LO

  • ClinicalStudiesNasogenian fold

    2

  • Protocol 20healthyvolunteers(40 60yearsold)withnasogenian folds. Formulation:2%LOemulsioncreamorplacebo Application:splitfaceandsplitneck2X/dayfor56days Measurementofdepth androughness byprofilometry andevaluationofsmoothness byadermatologist

    Reductionofnasogenian fold 2

    85% of volunteers hadan improvement

    LOstronglyreducestheappearanceofnasogenian foldafteronlyonemonth

    Reduction upto: 27.5%ofroughnesss 37.6%ofwrinkle depth

    LO2% LO2%

  • Reductionofnasogenian fold 2

    D0

    D60

    LOstronglyreducestheappearanceofnasogenian fold

  • Summary LOeffect 2

    HIF1AdipogenesisLipogenesisLipolysisAdiposetissue

    Nasogenian fold

    Reverseeffect ofLO

  • TT2peptide

    21LO

    +

    Bymodulangsenescenceprocess(progerin),

    TT2peptide targetsDERMIS restructurationfora

    remodellingeffectandwrinklesreduction

    Byinducinglipohormesis(HIF1),LO targetsHYPODERMIS restructurationfora

    lipofilling effectandnasogenian foldreduction

    21

    4LaSpiritCream

    forasynergisticefficacy

  • LaSpiritCream

    TT2peptide:Improves firmness &reduces wrinkles andsagging

    LO: Reversesagerelated lipoatrophy toplump theskin

    UNIQUE, SOPHISTICATED AND BIO-EFFICIENT ACTIVE INGREDIENTSAND DELIVERY SYSTEMS

    DELICIOUS TEXTURES THATDELIVER EXQUISIT SKIN FEEL

    Hydrogenated Lecithin (and)C1216Alcohols (and)Palmitic acid:Brings the

    phospholipids touch (coolness,softness)&comfort

    SodiumAcrylatesCopolymer (and)Lecithin:Brings alighttexturetothe

    emulsion

  • SKINBENEFITS AFTER1WEEK

    AFTER4WEEKS

    Theproductispleasant toapply 100% 100%

    Thetextureissmooth 96% 97%

    Theskinfeelssofter 92% 97% 87% IRISDATABASE*

    Theskinfeelssuppler 86% 91% 89%

    Theskinseemshydrated 85% 87% 84%

    Theskinismoreluminous 71% 73% 73%

    Theskinlooksmoreuniform 67% 79% 77%

    Thesignsoffatigue arelessvisible 69% 75%

    Theskintexture looksimproved 67% 75%

    Theskinfeelsfirmer 63% 73%

    Theskinhaveahealthyglow 56% 72%

    Theskinlooksvisiblysmooth out 51% 70%

    LaSpiritCreamTested by62women (45to70)twice aday for28day

    Compared toIris

    historical result on

    antiaging consumer

    tests2567tests

  • Conclusion

    Focusonstructuralaging

    YoungSkin MatureSkin

    Reverseeffect ofTT2peptide&LO

    Cutaneous aging characterized by a loss of elasticity, appearance of wrinkles

    Structural aging due to a lipoatrophy (loss of adipose tissue)

    Cellularagingwithaprogressivedysfunctionofthecellmetabolism(progerin)

  • JeanneCalment (1875 1997)

    ThankYou!

    Livingtotheageof122years=44724days